Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP2018 crossover trial in men with depression and erectile dysfunction
2020-000469-18Phase 2Unknown
- Sponsor
- Initiator Pharma A/S
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of IP2018 in erectile dysfunction (ED) and major depressive disorder (MDD) (2 arms), sponsored by Initiator Pharma A/S. Primary endpoints: Duration of at least 60% penile rigidity and Other RigiScan efficacy measures. Status: unknown.
02
Drugs
IP2018
03
Conditions
erectile dysfunction (ED)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2020-000469-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000469-18.